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ß cells of the endocrine pancreas have been shown to be sensitive to several lym-
phokines in vitro, notably the macrophage product IL-1, which can impair ß cell
insulin secretion (1-3) . Combinations ofIL-1 andeither TNF, lymphotoxin orIFN-
.y are cytotoxic to rat islet cell monolayer cultures, as shown by accelarated "Cr re-
lease and phase contrast microscopy (4) . These data suggest that lymphokines may
be important mediators oftheautoimmune destuction of0 cells during thedevelop-
ment of insulin-dependent diabetes (5) .
Allogeneic and even syngeneicmacrophages have been shown to lyse cultured mouse
islets (6) . In vivo, the macrophage toxin silica has been shown to reduce the inci-
dence ofautoimmune diabetes in both NOD mice (7) and BB rats (8), and to pre-
vent islet allograft rejection (9, 10) . These findings might suggest that macrophage
important inß cell destruction, both in autoimmune diabetes, and in
et allograft rejection .
Macrophage are knownto producelymphokines, notably IL-1 (11, 12), andthere
is evidence that other lymphokines such as IFN--y and TNF are released during
allograft rejection (13) . If islet cells are particularly sensitive to lymphokines, the
effects of such lymphokine release might explain why isolated islets appear espe-
cially susceptible to allograft rejection . Islets transplanted into the portal vein across
amajorhistocompatibility barrier in rats areusually rejected within 3 or4 d, whereas
kidney, heart, liver, and skin allografts are rejected in N7 or 8d (14, 15) . Similarly
transplantation of the whole pancreas as a vascularized organ results in islet rejec-
tionaround 7 to 8d (16, 17) . In addition, isolated islet rejection is difficult to prevent
using protocols that are effective in preventing the rejection of vascularized organ
allografts (18-20) . Itwould seem therefore that the effector mechanisms ofrejection
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of isolated islet allografts might be different in some way from that for other tissues
and organs.
Nevertheless, the rejection of isolated islet allografts displays features that are typ-
ical of the rejection ofvascularized organ and othertissue allografts, including genetic
control (21-23), a latent period before allograft destruction (24, 25), occurrence in
all vascularized regions of the body (20), an inverse relationship between graft size
and graft survival (26, 27), memory (28, 29), and T cell dependency (30, 31) . One
feature of islet allograft rejection that has not previously been examined and that
might be different from that for other tissues and organs is specificity. Skin allograft
rejection was shown to be highly specific using adult allophenic mouse donors pro-
duced by fusing two H-2-disparate embryonic blastocysts (32, 33). Similar results
have been reported more recently (34). If the effector mechanisms of islet allograft
rejection are in some way different, and if this difference is attributable to the de-
structive effects oflymphokine release on islet tissue, then it might be expected that
islet allograft rejection would be relatively nonspecific. Once local lymphokine re-
lease has been induced, there might be nonspecific bystander lysis of(3 cells, regard-
less of histocompatibility.
In the experiments described below we examined the specificity of islet allograft
rejection amongst mixed strain rat islets grafted to the renal subcapsular site.
Materials and Methods
For each experiment islets were isolated by ductal collagenase injection as previously de-
scribed (35) from three adult DA (RTI') and either three adult Lewis (LEW, RT1') or three
adult PVG (RT1`) rats to obtain at least 1,000 islets from each strain. Allogeneic islets from
a single donor strain were used throughout each experiment. Islets from each strain were
kept separately in 60-mm petri dishes, and viewed through a dissecting microscope against
a black background with side illumination.
200 syngeneic DA islets were handpicked with a siliconized glass micropipette and pedi-
atric aspirator, then placed into each of five numbered receivers that were kept on ice. The
receivers were constructed by cutting offthe lowermost portion of a universal container with
a heated scalpel, producing a receptacle with the shape of an inverted cone. 200 allogeneic
(LEW or PVG) islets were similarly placed into each offive other labeled receivers. To ensure
that a similar quantity of islet tissue was placed into each container, groups of similarly sized
islets were hand picked 20 at a time, and placed into each receiver in rotation. The receivers
containing DA and allogeneic (LEW or PVG) islets were then randomized separately, using
random number tables.
In each experiment islets were transplanted into three normal DA recipients beneath each
renal capsule using a minature blood clot technique as previously described (36). In the first
recipient, 200 syngeneic islets were placed under the light renal capsule, and 400 syngeneic
islets (two aliquots of200, mixed together gently but thoroughly with microdissecting forceps
before transplantation) under the left renal capsule. In the second recipient, 200 syngeneic
islets were placed under the upper pole of the right renal capsule, 200 allogeneic islets (LEW
or PVG) under the lower pole of the right renal capsule, and a mixture of 200 syngeneic
and 200 allogeneic islets (mixed together before transplantation) under the left renal capsule.
In the third recipient, 400 allogeneic islets (2 aliquots of 200, mixed together before trans-
plantation) were placed under the right renal capsule, and 200 allogeneic islets under the
left renal capsule.
Kidneys bearing islet grafts were excised 21 d after islet transplantation for acid alcohol
extraction and radioimmunoassay of insulin content (36, 37), or for histological examina-
tion. Paraffin-embedded sections were stained with hematoxylin and eosin as well as by a
two-layer immunoperoxidase technique for insulin and glucagon. Fresh frozen sections for
immunohistology were stained by a two-layer immunoperoxidase technique using a panelof mAbs directed at either DA class I (MN4), LEWclass I (NDS 60), PVG class I(OX 27),
or rat leukocyte common (OX 1 with OX 30) antigens, with antiinsulin and negative (OX
21) controls.
Statistical analysis of the results of insulin assay was carried out with the paired t test and
by analysis ofvariance;confidence intervalswere calculated from standard errors ofthe means.
Results
Table I displays the results of insulinextraction assays from six experiments with
LEW allogeneic islets and six experiments with PVG allogeneic islets, as well as
the results with data pooled from both experimental groups. The results of insulin
extraction from all kidneys grafted with only allogeneic islets are not listed, as none
contained >1 mU of insulin. The paired t test and analysis of variance showed no
significant differences between the insulin extracted from kidneys grafted with only
200 syngeneic islets, the insulin extracted from kidneys grafted with 200 syngeneic
and 200 allogeneic islets under separate poles of the kidney capsule, and the insulin
extracted from kidneys grafted with a mixture of 200 syngeneic and 200 allogeneic
islets. The quantity of insulin extracted from kidneys grafted with 400 syngeneic
islets was significantly greater than and approximately twice that extracted from
the other kidneys listed in Table I.
When examined by paraffin histology all grafts that were originally composed of
only syngeneic sites showed intact morphology with plentiful insulincontaining beta
cells (see Fig. 1 a); there was also preservation of glucagon-containing a cells (not
shown). No surviving islet tissue could be demonstrated at the site of any previous
SUTTON ET AL.
TABLE I
Results of Insulin Extraction and Radioimmunoassay
The results from kidneys in which either 200 or 400 allogeneic islets only were implanted
are not given as in no case was more than 1 mU insulin extracted.
Thepoweroftheseexperiments to detect adifference of20 mU of insulin was 0.45 (assum-
ing an SD of 34.8, i.e., the SD of the pooled difference between the insulin extractions of
columns three and four, with L at 0.05); to detect adifference of a 30 mU, 0.75; to detect
a difference of 40 mU, 0.95.
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Islets
Number of
experiments
Insulin (mU per kidney)
implanted beneath the renal
200 Syngeneic 400 Syngeneic
from kidneys bearing islets
capsule 21 d before removal'
200 Syngeneic 200 Syngeneic
200 Allogeneic 200 Allogeneic
(separate) (mixed)
DA and LEW
to DA: 6
Mean (SD) 72.3 (26.7) 119.0 (71.0) 66.0 (25.4) 82.5 (44.6)
95% CIs 44.4-100.3 44.5-193.5 39.3-92.7 35.7-129.3
DA and PVG
to DA: 6
Mean (SD) 40.8 (27.9) 127.0 (41.6) 63 .7 (37.4) 63.8 (26.0)
95% CIs 11 .9-70.1 83.3-170.7 24.4-102.9 36.5-91.2
Combined data: 12
Mean (SD) 56.5 (31.8) 123.0 (55.4) 64.8 (30.5) 73.2 (36.2)
95% CIs 36.4-76.8 87.8-158.2 45.5-84.2 50.2-96.1754
￿
SPECIFICITY OF REJECTION OF ALLOGENEIC ISLETS
FIGURE 1 .
￿
Immunoperoxidase-stained paraffin sections of kidneys (K)bearing subcapsular islet
grafts (1) originally composed of syngeneic islets only or mixed syngeneic and allogeneic islets :
(a) syngeneic only, stained for insulin (polyclonal guinea pig anti insulin, x250); (b) mixed syn-
geneic and allogeneic, stained for insulin (polyclonal guinea pigantiinsulin, x 250),showing similar
pattern of staining to that in a) .
graft originally composed of allogeneic islets, whether or not syngeneic islet tissue
had been grafted under the renal capsule of the same kidney . However, grafts origi-
nallycomposed ofmixed syngeneic and allogeneic islets displayed intact morphology
with evidence of both plentiful surviving /3 cells (see Fig. 1 b), and obvious preserva-
tion ofu cells (not shown), similar to the appearance of grafts ofsyngeneic islets alone .SUTTON ET AL .
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FIGURE 2 .
￿
Immunoperoxidase stained fresh frozen sections ofkidneys (K) bearing subcapsular
islet grafts (I) originally composed of syngeneic islets only or mixed syngeneic and allogeneic
islets : (a)DA islet graft toDA recipient stained forDA class I antigens (MN4, x 300), with graft
stainingmore pronounced than recipient kidney ; (b)mixedDA and LEW islet graft toDA recip-
ient stained forDA class I antigens (MN4, x 300), showing similar pattern ofstaining to that in a .
Immunohistology of fresh frozen tissue demonstrated uniform expression ofDA
class I antigens in recipient kidneys, and throughout the substanceof all grafts with
syngeneic DA islets, whether or not allogeneic islets had originally contributed to
their composition (see Fig . 2 a and b) . The expression ofDA class I antigens was756
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FIGURE 3 .
￿
Immunoperoxidase-stained fresh frozen sections of kidneys (K) bearing subcapsular
islet grafts (1) originally composed of mixed syngeneic and allogeneic islets : (a) mixed DA and
Lew islet graft to DA recipient stained for LEWclass I antigens (NDS 60, x300), showing no
uptake ofstain ; (b) mixed DA and PVG islet graft to DA recipient stained for PVG class I an-
tigens (0x27, x 300), again showing no uptake of stain .
more intense in all grafts than in recipient kidneys, again whether or not allogeneic
islets had originally contributedto theircomposition . No surviving allogeneic tissue,
either LEW or PVG, was demonstrable within any graft originally containing al-
logeneic islets, using the appropriate mAbs directed at class I antigens (see Fig. 3,SUTTON ET AL.
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FIGURE 4.
￿
Immunoperoxidase-stained fresh frozen sections of kidneys (K) bearing supcapsular
islet grafts (1) originally composed of syngeneic islets only or mixed syngeneic and allogeneic
islets : (a)DA islet graft to DA recipient stained for rat leukocyte common antigens (OX 1 with
OX 30, x 300); (b)mixedDA and LEW islet graft toDA recipient stained for rat leukocytecommon
antigens (OX 1 with OX 30, x 300), showing similar pattern of staining to that in a .
a and b) . The leucocyte infiltrates present within eight grafts originally composed
of only syngeneic islets and that present within four grafts originally composed of
mixed syngeneicand allogeneic islets were notnoticeably different (see Fig. 4, aand b) .758
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Discussion
These experiments were designed to detect quantitative differences between the
survival of syngeneic islets alone, allogeneic islets alone, and syngeneic islets mixed
with allogeneic islets, and then to confirmthe survival ofeither syngeneic or allogeneic
islets by immunihistology. The results of insulin extraction from kidneys bearing
grafts originally composed ofonly syngeneicislets substantiate the quantitative method
of assessment, as kidneys bearing grafts originally composed of400 syngeneicislets
alonecontained approximately twice as much insulinas kidneysbearing grafts orig-
inally composed of 200 syngeneic islets alone (see Table I). The pooled results of
all 12 insulin extraction experiments demonstrate this relationship most clearly, pre-
sumably because of the effects of islet aliquot randomization, as well as because of
adecrease in the standard error ofthe mean with increasing numbersof experiments.
The failure to extract insulin from any of the kidneys grafted originally with ei-
ther 200 or 400 allogeneic islets alone is compatible with the destruction of all al-
lografted tissue within 21 d of transplantation. Previously published metabolic and
histological data have demonstrated that both LEWand PVG islets grafted into un-
treated DA recipients are destroyed within several days of intraportal transplanta-
tion (20, 38, 39), and within N1 wk of renal subcapsular transplantation (20, 25).
This rapid destruction of freshly isolated islets after transplantation across a major
histocompatibility barrier is in keepingwith the results ofothers whohave used different
strains (14, 17). In this study, the results of insulin extraction were confirmed and
extended by immunohistology, whereneither LEW norPVG class I MHC-bearing
tissue could be demonstrated beneaththecapsuleofDA kidneys, regardless ofwhether
allogeneic islets were implanted alone or as a component of mixed syngeneic and
allogeneic islet grafts.
The finding that the insulin content of kidneys grafted originally with both 200
syngeneic and 200allogeneic islets wasnot significantly differentfrom kidneysgrafted
with 200 syngeneic islets alone suggests that the rejection of allogeneic islets is ex-
tremely specific. The careful mixing of syngeneic and allogeneic islets before trans-
plantation should have resulted in close approximation of syngeneic and allogeneic
islet tissue. Despite this close approximation of syngeneic and allogeneic islets the
effector mechanisms resultingin the destruction of the allogeneic islets had not ap-
parently damaged the syngeneic islets.
Thespecificity ofskin allograftrejection haspreviously been examined usingadult
allophenic mouse donors originally produced by fusing two H-2-disparate embryonic
blastocysts and observing the survival of graft melanoblasts and hair follicle cells
on parental strain recipients (32, 33); similar experiments have been carried out more
recently by others (34). These experiments demonstrated that skin allograft rejec-
tion was exquisitely specific for allogeneic cells, but theirdesign did not permit ac-
curate quantification of the survival of donor cells that were syngeneic with the pa-
rental recipients. Thus, although the specificity of the effector arm of the immune
response to target allogeneic cells was shown, it wasnotpossible to exclude the possi-
bility ofsimultaneous nonspecific immune destructionof some syngeneic cellsadja-
cent to allogeneic cells undergoing destruction.
However, the experiments reported here demonstrate the exquisite specificity of
islet allograft rejection in vivo, as there was no biochemical or histological evidence
that syngeneic islets were destroyed as a result of contiguous allograft rejection. IfSUTTON ET AL.
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nonspecific immune destructiondoes occurat all during islet allograft rejection, the
results of this experiment suggest that the extent to which such destruction might
occur is likely to be insignificant. This findingis not compatible with rejection being
a delayed-type hypersensitivity reaction mediated by T helper cells, but is compat-
ible with an effector response mediated by T cytotoxic cells(40). Ifso, then the rejec-
tion of isolated allogeneic islets occurs by a mechanism not different to that of other
tissues and organs. This is particularly relevant since islets, and especially a cells,
appear to be peculiarly vulnerable to the effector arm of both autoimmune (41) and
alloimmune responses (14, 16, 19, 20). The vulnerability of islets to alloimmune at-
tack would therefore seem to be attributable to the manner in which isolated islets
aretransplanted, includingtheir small size, exposed surface, and intravascular loca-
tion, rather than to intrinsic differences between the effector mechanisms ofthe re-
jection of islets and other tissues and organs. This explanation is supported by ex-
periments that have shown that isolated islet allografts transplanted within a
vascularized organallograft, either as a composite islet/kidney (39) or islet/liver (15)
graft or within the whole pancreas (16, 17) undergo rejection at a slower rate, com-
mensurate with rejection of the organ bearing the islets.
Thelack of damage to bystanding syngeneic islets, despite vigorous andcomplete
rejection ofallogeneic islets, raises questions about the effect oflymphokines on islet
cells, and more specifically, /3 cells. IL-1, TNF, IFN-'Y, and other lymphokines have
been shown to be produced locallyduring allograft rejection (13). Pronounced class
I expression was seen in grafts with syngeneic islets, both in grafts originally com-
posedof syngeneic islets alone, and in grafts ofmixedsyngeneicand allogeneic islets.
Whether syngeneic a cells in grafts originally composed of mixed syngeneic and
allogeneic islets upregulated their MHC products in response to lymphokines
specifically produced during contiguous allograft rejection remains undetermined.
Thus, the lack of bystander damage observed in the present experiments suggests
that either the deleterious effects of these lymphokines previously noted during in
vitro studies (1, 2, 4) are not relevant to in vivo events, or the production and subse-
quent activity oflymphokines is highly localized anddirected, and so syngeneicislet
damage does not occur. The latter possibility might usefully be investigated by
repeating the present experiments using mixed single cell preparations made from
syngeneic and allogeneic islets.
Summary
The specificity of rejection of isolated pancreatic islets was examined in the rat
using a quantitative model in which syngeneic (DA) or a mixture of syngeneic and
allogeneic (DA and LEW or PVG) islets were implanted beneath the capsule of the
kidney ofnondiabetic normal rats (DA) . 3 wk after transplantation total insulin ex-
traction assays ofthe kidney with its isletimplant together with immunohistological
examination of the site of transplantation for evidence of syngeneic or allogeneic
tissue demonstrated the total destruction of allogeneic islets without any evidence
ofdamage to syngeneic islets either distant or in immediate proximity to allogeneic
islets. Pancreatic islets, and especially 0 cells, appear to be particularly vulnerable
to the effector arm of both autoimmune and alloimmune responses, a vulnerability
that hasbeen attributed to the cytotoxiceffects oflymphokines, notablyIL-1, released
in both autoimmune and alloimmune responses. The experiments reported here760
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demonstrate not only the exquisite specificity of the allograft reaction but are not
compatible with a hypothesis that B cells within an intact islet are nonspecifically
susceptible to destruction by lymphokines.
Receivedfor publication 22 February 1989 and in revisedform I June 1989.
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